Metraipolis › archive › dc_49abd11ab508
Safety and Efficacy of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Proportions from… — Europe PMC PMID:40940825
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40940825
- DOI
- 10.3390/cancers17172727
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T10:19:48.665Z
- SHA-256 of the archived text
4005a196051e84a2e3f6fca7b3eb64c863c28c9868b698a76cdb8e29f699977a- Stable URL of this page
https://metraipolis.com/documento/dc_49abd11ab508
How to cite
Safety and Efficacy of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Proportions from… — Europe PMC PMID:40940825 — Europe PMC (en), https://europepmc.org/article/MED/40940825 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_49abd11ab508 (Metraipolis archive dc_49abd11ab508, sha256 4005a196051e84a2e3f6fca7b3eb64c863c28c9868b698a76cdb8e29f699977a)
BibTeX
@misc{dc49abd11ab508,
title = {Safety and Efficacy of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Proportions from… — Europe PMC PMID:40940825},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40940825},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_49abd11ab508; sha256 4005a196051e84a2e3f6fca7b3eb64c863c28c9868b698a76cdb8e29f699977a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40940825. Agents can read the archived copy with the MCP tool read_document.